Synlogic Inc logo

Synlogic Inc

NAS:SYBX (USA)  
$ 1.83 +0.01 (+0.56%) 07:08 PM EST
At Loss
P/B:
0.39
Market Cap:
$ 20.85M
Enterprise V:
$ -9.74M
Volume:
43.75K
Avg Vol (2M):
187.38K
Also Trade In:
Volume:
43.75K
At Loss
Avg Vol (2M):
187.38K

Business Description

Description
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 2.76
Equity-to-Asset 0.57
Debt-to-Equity 0.41
Debt-to-EBITDA -0.31
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -9.29
Distress
Grey
Safe
Beneish M-Score -0.9
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 44.1
9-Day RSI 41.38
14-Day RSI 38.59
6-1 Month Momentum % -54.84
12-1 Month Momentum % -78.32

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.45
Quick Ratio 2.45
Cash Ratio 2.34
Days Sales Outstanding 162.41

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -53.4
Shareholder Yield % -88.95

Financials (Next Earnings Date:2024-03-29 Est.)

SYBX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:SYBX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Synlogic Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 3.371
EPS (TTM) ($) -10.752
Beta 0.49
Volatility % 109.96
14-Day RSI 38.59
14-Day ATR ($) 0.143831
20-Day SMA ($) 1.8215
12-1 Month Momentum % -78.32
52-Week Range ($) 1.55 - 10.640999
Shares Outstanding (Mil) 11.65

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Synlogic Inc Filings

Filing Date Document Date Form
No Filing Data

Synlogic Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Synlogic Inc Frequently Asked Questions

What is Synlogic Inc(SYBX)'s stock price today?
The current price of SYBX is $1.83. The 52 week high of SYBX is $10.64 and 52 week low is $1.55.
When is next earnings date of Synlogic Inc(SYBX)?
The next earnings date of Synlogic Inc(SYBX) is 2024-03-29 Est..
Does Synlogic Inc(SYBX) pay dividends? If so, how much?
Synlogic Inc(SYBX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1